Citius Pharmaceuticals Inc. (CTXR) shares are trading at higher $1.08 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $1.97 and the low is $0.40. Over the last 52 weeks, CTXR is up 61.19% while the S&P 500 is up 18.10%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, CTXR reported a profit of $4000.0. Citius Pharmaceuticals Inc. also saw revenues increase to $4.69 million. In addition, CTXR has free cash flow of -$13.57 million as of 06-2020. The company’s EBITDA came in at -$4.69 million which compares well with its peers.
CTXR Return on Equity (ROE) is -69.20%, and its Return on Assets is -53.90%. All told, it is clear that, CTXR needs to be on your watchlist.
Find out when CTXR reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. CTXR has a short ratio of 0.50 and outstanding shares of 41.60M.
CTXR has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.55. Citius Pharmaceuticals Inc. CTXR also noted assets of $38.4 million at the end of the last quarter. Investors should also keep an eye on sector updates as CTXR has historically followed its peers on positive news.
All told, Citius Pharmaceuticals Inc. CTXR has strung together solid data and demonstrated underlying fundamentals. At its current valuation, CTXR represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Citius Pharmaceuticals Inc. CTXR is now commanding a market cap of 60.48M and a float of 39.36M. CTXR is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of CTXR stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in CTXR, either long or short, and we have not been compensated for this article.